The Effectivity of Combination of Standard Interferon-alpha

被引:0
|
作者
Ozgunes, Nail [1 ]
Sargin, Fatma [1 ]
Yazici, Saadet [1 ]
Ceylan, Nuket [1 ]
Ucisik, Ayse Canan [1 ]
Ergen, Pinar [1 ]
Dogru, Arzu [1 ]
Aydin, Ozlem [1 ]
机构
[1] SB Goztepe Egitim & Arastirma Hastartesi, Infeks Elastaliklan & Klin Mikrobiyol Klin, Istanbul, Turkey
来源
关键词
Chronic hepatitis C; interferon alpha; pegylated interferon alpha; ribavirin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was done in order to evaluate the effectivity of combination therapy of standard interferon alpha (IFN-alpha) + ribavirin and pegylated IFN-alpha (PEG-IFN-alpha) + ribavirin in patients with chronic hepatitis C between 2003-2005 years in our clinic. Totally 52 patients were included in the study. In the combination treatment protocols, standard IFN-alpha 2 alpha or 2b plus ribavirin was given in 35 patients (group I) and PEG-IFN-a plus ribavirin in 17 patients (group II). Duration of treatment was 12 months. Rate of biochemical and virological responses at the end of the therapy and sustained response were 66.6%, 78.7%, 57.7% in group I and 71.4%, 85%, 66.7% in group II, respectively In conclusion, treatment protocols was effective in both groups and the rate of biochemical and virologic responses at the end of the therapy and sustained response were higher in group II than group I but the differences between groups were not significant. In according to the results of this study; PEG-IFN should be preferred to standard IFN-alpha.
引用
收藏
页码:61 / 64
页数:4
相关论文
共 50 条
  • [21] Ribavirin and consensus interferon-alpha combination therapy of acute arenaviral disease
    Gowen, B
    Smee, D
    Wong, MH
    Pace, A
    Jung, KH
    Bailey, K
    Blatt, L
    Sidwell, R
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A81 - A81
  • [22] POTENTIATION OF INTERFERON-ALPHA INVITRO ANTIVIRAL ACTIVITY BY INTERFERON-ALPHA IS NOT ABROGATED BY ANTIBODY TO INTERFERON-GAMMA
    CAPOBIANCHI, MR
    MATTANA, P
    DIANZANI, F
    JOURNAL OF INTERFERON RESEARCH, 1993, 13 (01): : 53 - 55
  • [23] Combination of lactam steroids with interferon-alpha for the treatment of pancreatic adenocarcinoma cells
    Trafalis, DT
    Tsavdaridis, D
    Papageorgiou, A
    Stravoravdi, P
    Barich, A
    Camoutsis, C
    Karamanakos, P
    Koutsilieris, M
    Ginopoulos, P
    Sougleri, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, : 89 - 89
  • [24] Human interferon-alpha receptor: Identification of the region involved in binding to interferon-alpha B
    Hirata, MH
    Sackett, D
    Hirata, RDC
    Nguyen, NY
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1996, 16 (10): : 845 - 852
  • [25] BEHAVIORAL-EFFECTS OF MOUSE INTERFERON-ALPHA AND INTERFERON-GAMMA AND HUMAN INTERFERON-ALPHA IN MICE
    CRNIC, LS
    SEGALL, MA
    BRAIN RESEARCH, 1992, 590 (1-2) : 277 - 284
  • [26] INVIVO EFFECTS OF COMBINATION TREATMENT WITH RECOMBINANT INTERFERON-GAMMA AND INTERFERON-ALPHA IN METASTATIC MELANOMA
    OSANTO, S
    JANSEN, R
    NAIPAL, AMIH
    GRATAMA, JW
    VANLEEUWEN, A
    CLETON, FJ
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (06) : 1001 - 1006
  • [27] Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopeniaStandard Interferon-alpha in Kombination mit Ribavirin bei Hepatitis C Patienten mit fortgeschrittener Lebererkrankung und Thrombozytopenie
    Harald Hofer
    Calin Gurguta
    Ulrike Bergholz
    Petra Steindl-Munda
    Peter Ferenci
    Wiener klinische Wochenschrift, 2006, 118 : 595 - 600
  • [28] COMBINATION OF RECOMBINANT INTERFERON-ALPHA AND INTERFERON-GAMMA IN TREATMENT OF CHRONIC HEPATITIS-B
    CARRENO, V
    MORA, I
    LANCET, 1987, 2 (8567): : 1086 - 1086
  • [29] Comparison of interleukin-2, interferon-alpha, 5-fluorouracyl combination and Interferon-alpha, vinblastin treatment in metastatic renal cell cancer.
    Gyergyay, F
    Rathonyi, E
    Biro, K
    Nagyivanyi, K
    Bodrogi, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 425S - 425S
  • [30] INTERFERON-ALPHA IS A REPRODUCTIVE HORMONE
    CHARD, T
    JOURNAL OF ENDOCRINOLOGY, 1991, 131 (03) : 337 - 338